Skip to main content
. Author manuscript; available in PMC: 2018 Oct 4.
Published in final edited form as: Int J Gynecol Pathol. 2017 May;36(3):240–252. doi: 10.1097/PGP.0000000000000325

TABLE 3.

Correlation of IHC markers with recurrent and nonrecurrent GCT

Marker H Score n (%) P
Nonrecurrent (n = 71)* Recurrent (n = 12)
Calretinin Negative 15 (21.1) 1 (10.0) 0.71
Low: ≤50% 25 (35.2) 4 (40.0)
High: >50% 31 (43.7) 5 (50.0)
Inhibin Negative 41 (59.4) 3 (30.0) 0.02
Low: ≤50% 24 (34.8) 4 (40.0)
High: >50% 4 (5.8) 3 (30.0)
Her2 Negative 71 (100.0) 8 (80.0) 0.014
High≥80% 0 (0.0) 2 (20.0)
CD56 Negative 28 (38.4) 0 (0.0) 0.001
Low: ≤80% 17 (23.3) 0 (0.0)
High: >80% 28 (30.4) 10 (100.0)
VEGF Negative 2 (2.8) 0 (0.0) 0.74
Low: ≤80% 2 (2.8) 0 (0.0)
High: >80% 67 (94.4) 10 (100.0)
SMAD3 Negative 51 (72.9) 0 (0.0) 0.0001
Low: ≤80% 11 (15.7) 2 (20.0)
High: >80% 8 (11.4) 8 (80.0)
GATA4 Negative 53 (74.6) 6 (60.0) 0.15
Low: ≤80% 15 (21.1) 2 (20.0)
High: >80% 3 (4.2) 2 (20.0)
*

Data is missing in some cases.

Bold values are statistically significant.

GCT indicates granulosa cell tumors; IHC, immunohistochemistry.